• 5570 Citations
  • 42 h-Index
1988 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giuseppe Tambussi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 31 Similar Profiles
HIV-1 Medicine & Life Sciences
HIV Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Human immunodeficiency virus 1 Agriculture & Biology
Highly Active Antiretroviral Therapy Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences
HIV infections Agriculture & Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2018

  • 5570 Citations
  • 42 h-Index
  • 177 Article
  • 1 Chapter

Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial

Schlusser, KE., Sharma, S., de la Torre, P., Tambussi, G., Draenert, R., Pinto, AN., Metcalf, JA., German, D., Neaton, JD., Laeyendecker, O. & Group, F. T. INSIGHT. START. S., 2018, In : AIDS and Behavior. 22, 7, p. 2277-2283 7 p.

Research output: Contribution to journalArticle

Self Report
HIV Infections
Random Allocation

HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapy

Logerot, S., Rancez, M., Charmeteau-De Muylder, B., Figueiredo-Morgado, S., Rozlan, S., Tambussi, G., Beq, S., Couëdel-Courteille, A. & Cheynier, R., 2018, In : AIDS. 32, 6, p. 715-720 6 p.

Research output: Contribution to journalArticle

Highly Active Antiretroviral Therapy

Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load

Galizzi, N., Galli, L., Poli, A., Gianotti, N., Carini, E., Bigoloni, A., Tambussi, G., Nozza, S., Lazzarin, A., Castagna, A., Mancusi, D. & Termini, R., 2018, In : PLoS One. 13, 2, e0191300.

Research output: Contribution to journalArticle

viral load
Human immunodeficiency virus 1
Viral Load

Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control

Malnati, MS., Ugolotti, E., Monti, MC., De Battista, D., Vanni, I., Bordo, D., Sironi, F., Larghero, P., Di Marco, E., Biswas, P., Poli, G., Vicenzi, E., Riva, A., Tarkowski, M., Tambussi, G., Nozza, S., Tripodi, G., Marras, F., De Maria, A., Pistorio, A. & 1 others, Biassoni, R., 2017, In : Scientific Reports. 7, 25, 42470.

Research output: Contribution to journalArticle

HLA-C Antigens
HLA-B Antigens

Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial

INSIGHT (International Network for Strategic Initiatives in Global HIV Trials) START (Strategic Timing of Antiretroviral Treatment) Study Group, 2017, In : Journal of the American Heart Association. 6, 5, e004987.

Research output: Contribution to journalArticle

Cardiovascular Diseases
HDL Cholesterol
LDL Cholesterol